We encourage you to republish this article online and in print, it’s free under our creative commons attribution license, but please follow some simple guidelines:
  1. You have to credit our authors.
  2. You have to credit SciDev.Net — where possible include our logo with a link back to the original article.
  3. You can simply run the first few lines of the article and then add: “Read the full article on SciDev.Net” containing a link back to the original article.
  4. If you want to also take images published in this story you will need to confirm with the original source if you're licensed to use them.
  5. The easiest way to get the article on your site is to embed the code below.
For more information view our media page and republishing guidelines.

The full article is available here as HTML.

Press Ctrl-C to copy

The introduction of ethical regulations in medicine in China might seem at odds with the country's social and moral reality, and there are concerns about whether China is prepared to embrace the standards it claims to have adopted.

Although all countries need to develop up-to-date bioethics, China is unique in having to deal with social, institutional and economic reforms, and the introduction of a modern system of education, technical and legal international standards at the same time.

In an article in this month's Nature Reviews Genetics, Ole Döring reviews the current policies on medical ethics in China, and reflects on the conceptual, legal and practical challenges particularly surrounding informed consent.

Link to full Nature Reviews Genetics article

Reference: Nature Reviews Genetics 4, 233 (2003)

Related topics